Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
Shah, Neil P., Kasap, Corynn, Weier, Christopher, Balbas, Minna, Nicoll, John M., Bleickardt, Eric, Nicaise, Claude, Sawyers, Charles L.
Published in Cancer cell (09.12.2008)
Published in Cancer cell (09.12.2008)
Get full text
Journal Article
Dasatinib (BMS-354825) is active in Philadelphia chromosome–positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure
Quintas-Cardama, Alfonso, Kantarjian, Hagop, Jones, Dan, Nicaise, Claude, O'Brien, Susan, Giles, Francis, Talpaz, Moshe, Cortes, Jorge
Published in Blood (15.01.2007)
Published in Blood (15.01.2007)
Get full text
Journal Article
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
Talpaz, Moshe, Shah, Neil P, Kantarjian, Hagop, Donato, Nicholas, Nicoll, John, Paquette, Ron, Cortes, Jorge, O'Brien, Susan, Nicaise, Claude, Bleickardt, Eric, Blackwood-Chirchir, M. Anne, Iyer, Vishwanath, Chen, Tai-Tsang, Huang, Fei, Decillis, Arthur P, Sawyers, Charles L
Published in The New England journal of medicine (15.06.2006)
Published in The New England journal of medicine (15.06.2006)
Get full text
Journal Article
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus
McLaren, C, Rozencweig, M, Beltangady, M, Nicaise, C, Yarchoan, R, Dolin, R, Allan, J D, Cooley, T P, Seidlin, M, Smaldone, L F
Published in Clinical infectious diseases (01.02.1993)
Published in Clinical infectious diseases (01.02.1993)
Get more information
Journal Article
Efficacy of Dasatinib in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CML-CP)
Cortes, Jorge, O'Brien, Susan, Jones, Dan, Koller, Charles, Borthakur, Gautam, Nicaise, Claude, Henderson, Laverne, Ferrajoli, Alessandra, Kantarjian, Hagop
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Potent Transient Inhibition of BCR-ABL by Dasatinib Leads to Complete Cytogenetic Remissions in Patients with Chronic Myeloid Leukemia: Implications for Patient Management and Drug Development
Shah, Neil P., Nicoll, John M., Bleickardt, Eric, Nicaise, Claude, Paquette, Ronald L., Sawyers, Charles L.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Cytopenias in Patients (pts) with Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP) Treated with Dasatinib (SPRYCEL®): Clinical Features and Management, Including Outcome after Hematopoietic Growth Factor Therapy
Quintas-Cardama, Alfonso, Kantarjian, Hagop M., Nicaise, Claude, Garcia-Manero, Guillermo, O'Brien, Susan, Ravandi, Farhad, Faderl, Stefan
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Dasatinib (Sprycel™) Therapy for Patients with Systemic Mastocytosis
Verstovsek, Srdan, Kantarjian, Hagop, Cortes, Jorge, Ravandi-Kashani, Farhad, Borthakur, Gautam, Nicaise, Claude, Sams, Inga, Giles, Francis, Tefferi, Ayalew
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Correlation of Clinical Response to Dasatinib (BMS-354825) with BCR-ABL Mutation Status in Imatinib- Resistant Patients (pts) with Chronic Myeloid Leukemia (CML) Treated at MD Anderson Cancer Center (MDACC)
Jabbour, Elias, Cortes, Jorge, Talpaz, Moshe, Jones, Dan, O'Brien, Susan, Nicaise, Claude, Kantarjian, Hagop
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Molecular Response According to Type of Preexisting BCR-ABL Mutations after Second Line Dasatinib Therapy in Chronic Phase CML Patients
Mueller, Martin C., Erben, Philipp, Ernst, Thomas, Giehl, Michelle, Schenk, Thomas, Hoffmann, Jana, Lauber, Stephanie, Kruth, Jens, Hanfstein, Benjamin, Bleickardt, Eric, Nicaise, Claude, Hehlmann, Rüdiger, Hochhaus, Andreas
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Pleural Effusion in Patients (pts) with Chronic Myelogenous Leukemia (CML) Treated with Dasatinib after Imatinib Failure
Quintas-Cardama, Alfonso, Kantarjian, Hagop M., Munden, Reginald, Talpaz, Moshe, Bruzzi, John, O'Brien, Susan, Garcia-Manero, Guillermo, Nicaise, Claude, Cortes, Jorge
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Response to Dasatinib after Imatinib Failure According to Type of Preexisting BCR-ABL Mutations
Müller, Martin C., Erben, Philipp, Schenk, Thomas, Lauber, Stephanie, Kruth, Jens, Hoffmann, Jana, Ernst, Thomas, Lahaye, Tanja, Metzgeroth, Georgia, Acevedo, Michael, Nicaise, Claude, Hehlmann, Rudiger, Hochhaus, Andreas
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article
Molecular Analysis of Dasatinib Resistance Mechanisms in CML Patients Identifies Novel BCR-ABL Mutations Predicted To Retain Sensitivity to Imatinib: Rationale for Combination Tyrosine Kinase Inhibitor Therapy
Shah, Neil P., Nicoll, John M., Branford, Susan, Hughes, Timothy P., Paquette, Ronald L., Talpaz, Moshe, Nicaise, Claude, Huang, Fei, Sawyers, Charles L.
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients
Rozencweig, M, McLaren, C, Beltangady, M, Ritter, J, Canetta, R, Schacter, L, Kelley, S, Nicaise, C, Smaldone, L, Dunkle, L
Published in Reviews of infectious diseases (01.07.1990)
Get more information
Published in Reviews of infectious diseases (01.07.1990)
Journal Article
Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer
GOODMAN, G. E, HELLSTROM, I, HELLSTROM, K. E, YELTON, D. E, MURRAY, J. L, O'HARA, S, MEAKER, E, ZEIGLER, L, PALAZOLLO, P, NICAISE, C, USAKEWICZ, J
Published in Cancer Immunology Immunotherapy (01.07.1993)
Published in Cancer Immunology Immunotherapy (01.07.1993)
Get full text
Journal Article
Megestrol acetate: clinical experience
Schacter, Lee, Rozencweig, Marcel, Canetta, Renzo, Kelley, Susan, Nicaise, Claude, Smaldone, Laurie
Published in Cancer treatment reviews (01.03.1989)
Published in Cancer treatment reviews (01.03.1989)
Get full text
Journal Article
Phase I trial of murine monoclonal antibody L6 in combination with subcutaneous interleukin-2 in patients with advanced carcinoma of the breast, colorectum, and lung
Ziegler, L D, Palazzolo, P, Cunningham, J, Janus, M, Itoh, K, Hayakawa, K, Hellstrom, I, Hellstrom, K E, Nicaise, C, Dennin, R
Published in Journal of clinical oncology (01.09.1992)
Published in Journal of clinical oncology (01.09.1992)
Get more information
Journal Article
Effects of Therapy With Didanosine on Hematologic Parameters in Patients With Advanced Human Immunodeficiency Virus Disease
Schacter, Lee P., Rozencweig, Marcel, Beltangady, Mohan, Allan, J. Davis, Canetta, Renzo, Cooley, Timothy P., Dolin, Raphael, Kelley, Susan, Lambert, John, Liebman, Howard A., Messina, Marianne, Nicaise, Claude, Seidlin, Mindell, Valentine, Fred T., Yarchoan, Robert, Smaldone, Laurie F.
Published in Blood (15.12.1992)
Published in Blood (15.12.1992)
Get full text
Journal Article